Hemoglobin A1c and Early Gestational Diabetes
Background: Screening for diabetes in early pregnancy is recommended for high-risk women, however, the optimal test for the diagnosis of early gestational diabetes mellitus (GDM) is unknown. Thus, the objective of this study was to evaluate hemoglobin A1c (HbA1c) as a diagnostic test for early GDM compared with two-step testing. Materials and Methods: Retrospective cohort of women with prior GDM or obesity who had HbA1c and two-step testing <21 weeks' gestation. Early GDM was diagnosed by 1 hour, 50 g oral glucose challenge test (GCT) ≥135 mg/dL and ≥2 abnormal values on 3 hour, 100 g oral glucose tolerance test or GCT >200 mg/dL. The area under the receiver operating characteristic curve (AUC) evaluated HbA1c for diagnosis of early GDM. Results: Of 243 women, 14 (5.8%) had early GDM by two-step testing. Median HbA1c levels were higher among women with GDM versus those without GDM (5.8% vs. 5.3%, p < 0.001). The AUC for HbA1c compared with two-step testing was 0.80 (95% CI 0.69-0.91). The optimal HbA1c threshold was 5.6% (64% sensitivity, 84% specificity). Conclusions: HbA1c is moderately predictive of early GDM compared with two-step testing, and a threshold lower than that used for diabetes diagnosis among nonpregnant adults is justified.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Journal of women's health (2002) - 29(2020), 12 vom: 18. Dez., Seite 1559-1563 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Battarbee, Ashley N [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers |
---|
Anmerkungen: |
Date Completed 19.04.2021 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1089/jwh.2019.8203 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM312553293 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM312553293 | ||
003 | DE-627 | ||
005 | 20231225144646.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1089/jwh.2019.8203 |2 doi | |
028 | 5 | 2 | |a pubmed24n1041.xml |
035 | |a (DE-627)NLM312553293 | ||
035 | |a (NLM)32678995 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Battarbee, Ashley N |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hemoglobin A1c and Early Gestational Diabetes |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.04.2021 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Background: Screening for diabetes in early pregnancy is recommended for high-risk women, however, the optimal test for the diagnosis of early gestational diabetes mellitus (GDM) is unknown. Thus, the objective of this study was to evaluate hemoglobin A1c (HbA1c) as a diagnostic test for early GDM compared with two-step testing. Materials and Methods: Retrospective cohort of women with prior GDM or obesity who had HbA1c and two-step testing <21 weeks' gestation. Early GDM was diagnosed by 1 hour, 50 g oral glucose challenge test (GCT) ≥135 mg/dL and ≥2 abnormal values on 3 hour, 100 g oral glucose tolerance test or GCT >200 mg/dL. The area under the receiver operating characteristic curve (AUC) evaluated HbA1c for diagnosis of early GDM. Results: Of 243 women, 14 (5.8%) had early GDM by two-step testing. Median HbA1c levels were higher among women with GDM versus those without GDM (5.8% vs. 5.3%, p < 0.001). The AUC for HbA1c compared with two-step testing was 0.80 (95% CI 0.69-0.91). The optimal HbA1c threshold was 5.6% (64% sensitivity, 84% specificity). Conclusions: HbA1c is moderately predictive of early GDM compared with two-step testing, and a threshold lower than that used for diabetes diagnosis among nonpregnant adults is justified | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a diagnosis | |
650 | 4 | |a early gestational diabetes | |
650 | 4 | |a hemoglobin A1c | |
650 | 4 | |a pregnancy | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a Glycated Hemoglobin A |2 NLM | |
700 | 1 | |a Grant, Jacqueline H |e verfasserin |4 aut | |
700 | 1 | |a Vladutiu, Catherine J |e verfasserin |4 aut | |
700 | 1 | |a Menard, M Kathryn |e verfasserin |4 aut | |
700 | 1 | |a Clark, Michael |e verfasserin |4 aut | |
700 | 1 | |a Manuck, Tracy A |e verfasserin |4 aut | |
700 | 1 | |a Venkatesh, Kartik K |e verfasserin |4 aut | |
700 | 1 | |a Boggess, Kim A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of women's health (2002) |d 2002 |g 29(2020), 12 vom: 18. Dez., Seite 1559-1563 |w (DE-627)NLM12347809X |x 1931-843X |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2020 |g number:12 |g day:18 |g month:12 |g pages:1559-1563 |
856 | 4 | 0 | |u http://dx.doi.org/10.1089/jwh.2019.8203 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2020 |e 12 |b 18 |c 12 |h 1559-1563 |